Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities

NARecruitingINTERVENTIONAL
Enrollment

2,880

Participants

Timeline

Start Date

July 24, 2022

Primary Completion Date

December 18, 2025

Study Completion Date

June 30, 2026

Conditions
AgingFunctional RecoverySkilled Nursing FacilityMedically ComplexDeconditioning
Interventions
OTHER

i-STRONGER

An 8RM is the dose necessary for most effective strength gains in community-dwelling older adults, and is equivalent to 80% of a one repetition max, which is the maximal load needed to voluntarily complete one repetition of a given exercise with proper form. Clinicians will tailor the intervention for each activity, so the patient achieves 8 repetitions with failure on the 9th repetition. Failure is the inability to complete a repetition through the full, available range of motion without significant compensation. Further, high-intensity dosing requires continuous, volitional effort from the patient; therefore, incorporation of motivational interviewing strategies across sessions will maximize patient effort and self-efficacy.

OTHER

Usual Care

Usual Care SNFs will continue with routine collection and documentation of physical performance outcomes (gait speed, SPPB, Modified Barthel ADL Index) as standard practice. Furthermore, a combination of chart reviews and on-site or remote observation will allow for characterization of usual care components for descriptive comparison. Importantly, the Usual Care SNF including the facility, rehabilitation clinicians, and patients will not have access to i-STRONGER materials.

Trial Locations (2)

75034

RECRUITING

Aegis Therapies, Frisco

80045

RECRUITING

University of Colorado Denver, Anschutz Medical Campus, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aegis Therapies, Inc.

UNKNOWN

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Colorado, Denver

OTHER

NCT05492240 - Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities | Biotech Hunter | Biotech Hunter